USPTO 2015–2025 USPTO PatentsView Foreign Corporation

OUR United Corporation

USPTO PatentsView assignee record - 82 granted patents across 17 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, OUR ranks #4,349 of 49,997 tracked US assignees by granted-patent volume, with 82 patents across 17 technology areas.

#4,349
of 49,997 US assignees by volume
Top 7%
by Innovation Score (55.4/100)
15.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R4349 · Foreign Corporation #4,349 · 82 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 82 grants
  • TOP-DECILE #4,349/49,997
  • PHOTO-FINISH Magneti Marelli S p A
  • CPC-FOCUS A61N · 17 areas
  • INNOV-PAR 55.4/100
  • CLAIMS-RICH 15.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Magneti Marelli S.p.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around OUR

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows OUR's Innovation Score is 55.4/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where OUR's grants concentrate

OUR United Corporation is a focused PatentsView assignee: 17 CPC subclasses with 79.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (29 grants) versus a trough of 6 in 2020. By volume, OUR sits between Magneti Marelli S.p.A. and Reliaquest Holdings, LLC.

OUR's three-year grant acceleration

From 2019–2021 to 2022–2024, OUR United Corporation moved from 20 to 49 grants (2.45x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at OUR's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows OUR holds 82 patents at rank #4,347, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near OUR

By rank, the assignees closest to #4,347 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in OUR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OUR, neither rank-band nor same-CPC leaders (those blocks stay above).

OUR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 202020212022202320242025 13
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
OUR United Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 6 7.3%
2021 14 17.1%
2022 12 14.6%
2023 8 9.8%
2024 29 35.4%
2025partial year 13 15.9%

Where it ranks

Overall rank by patents

#4,349

of 49,997 tracked assignees

Innovation Score

55.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

OUR United Corporation's patent record in context - here's where to go next.

  • OUR United Corporation's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 79.3% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #4,349 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare OUR United Corporation against Magneti Marelli S.p.A., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 55.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.